JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.41898?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Authors: Dariush Mozaffarian, M.D., Dr.P.H., of the Tufts Friedman School of Nutrition Science and Policy in Boston, and Pierre Lemieux, Ph.D., of Acasti Pharma, Inc., in Laval, Canada, are the corresponding authors.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.